| 04/24 | ChromaDex Furthers TRU NIAGEN® Global Expansion in Canada with WELL Health Technologies | GL |
| 04/24 | Q & M DENTAL SINGAPORE : Disclosure Of Changes In Interest Of Director And Chief Executive Officer - Dr Ng Chin Siau | PU |
| 04/24 | INTEGRA : 1Q Earnings Snapshot | AQ |
| 04/24 | DAVITA : The Aspen Group Applauds the New Payment Model Pilots Introduced by the Center for Medicare & Medicaid Innovation | PU |
| 04/24 | ABIOMED INC : Other Events (form 8-K) | AQ |
| 04/24 | INTEGRA LIFESCIENCES HOLDINGS CORP : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) | AQ |
| 04/24 | THERMO FISHER : 1Q Earnings Snapshot | AQ |
| 04/24 | ANTHEM : Insurer Anthem tops 1Q expectations, raises 2019 forecast | AQ |
| 04/24 | ANTHEM, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) | AQ |
| 04/24 | MOLECULIN BIOTECH, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
| 04/24 | CANCER GENETICS : DNA Rearrangement May Predict Resistance in Multiple Myeloma | AQ |
| 04/24 | DAVITA : Helping Patients Along Their Kidney Transplant Journey | PR |
| 04/24 | ANTHEM : Reports First Quarter 2019 Results, Raises Full Year Outlook | BU |
| 04/24 | UNITED THERAPEUTICS CORPORATION : To Report First Quarter 2019 Financial Results Before The Market Opens On Wednesday, May 1, 2019 | PR |
| 04/24 | THERMO FISHER SCIENTIFIC : Reports First Quarter 2019 Results | PR |
| 04/24 | Integra LifeSciences Reports First Quarter 2019 Financial Results | GL |
| 04/24 | AXONICS MODULATION TECHNOLOGIES : ® to Report First Quarter 2019 Financial Results and Host a Conference Call on May 8 | BU |
| 04/24 | MOLOGEN AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQ |
| 04/24 | NOVARTIS : 1Q Earnings Snapshot | AQ |
| 04/24 | UNITEDHEALTH : Despite talk of universal health care, UnitedHealth a robust stock | AQ |
| 04/24 | MERIT MEDICAL SYSTEMS, INC. (NASDAQ : MMSI) Files An 8-K Results of Operations and Financial Condition | AQ |
| 04/24 | EISAI : to Present Latest Data on Lemborexant and Perampanel at Annual American Academy of Neurology Meeting | AQ |
| 04/24 | ATTENDO PUBL : report for the first quarter 2019 to be published on 3 May - Invitation to teleconference | AQ |
| 04/24 | BERGENBIO ASA : Invitation to First Quarter Presentation and Webcast | AQ |
| 04/24 | AQUABOUNTY TECHNOLOGIES, INC. (LON : ABTU) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | AQ |
| 04/24 | LHC : LIFE HEALTHCARE GROUP HOLDINGS LIMITED - Trading statement | PU |
| 04/24 | EL EN : Notice to Shareholders | PU |
| 04/24 | PHYLOGICA : Change of Director's Interest Notice | PU |
| 04/24 | PW MEDTECH : Circulars | PU |
| 04/24 | SHIELD THERAPEUTICS : STX); Swissmedic approves major extension of Feraccru in Switzerland | AQ |
| 04/24 | VOLITIONRX : Executive Interview - VolitionRx (VNRX) | AQ |
| 04/24 | AXOGEN : shares slip on expanded Avance nerve graft study | AQ |
| 04/24 | MICROBOT MEDICAL : Strengthens Global IP Portfolio with Canadian Notice of Allowance for a Patent Application for a Shunt Stenosis Prevention System | AQ |
| 04/24 | MALLINCKRODT : Lupus Phase 4 Clinical Study for Acthar Gel (Repository Corticotropin Injection) Completes Enrollment in Difficult-to-Manage Population | AQ |
| 04/24 | ATHERSYS : HEALIOS K.K. Announces Enrollment of First Patient in Japan in the ONE-BRIDGE Study of MultiStem Treatment for Acute Respiratory Distress Syndrome | AQ |
| 04/24 | UROGEN PHARMA : Announces Early Stage Feasibility Agreement with Janssen | AQ |
| 04/24 | TROVAGENE : Announces Data Demonstrating Significant Synergy of Onvansertib in Combination with Venetoclax in Cell Model of Venetoclax-Resistant AML | AQ |
| 04/24 | AKARI THERAPEUTICS : Announces Positive Initial Phase II Clinical Data in Orphan Skin Disease Bullous Pemphigoid | AQ |
| 04/24 | ARCA BIOPHARMA : Announces Steering Committee of Leading International Cardiology and Electrophysiology Experts for PRECISION-AF Phase 3 Clinical Trial | AQ |
| 04/24 | VERITAS FARMS : Appoints Michael D. Pelletier as Chief Financial Officer | AQ |
| 04/24 | BRIACELL THERAPEUTICS : Announces Publication at American Society of Clinical Oncology (ASCO) Meeting and Presentation at Precision Breast Cancer Summit in Boston | AQ |
| 04/24 | LABORATORY OF AMERICA : OmniSeq and LabCorp Extend Exclusive Distribution Pact and Complete Follow-On Investment Agreement | AQ |
| 04/24 | PLURISTEM THERAPEUTICS : Issues Shareholder Update | AQ |
| 04/24 | LABORATORY OF AMERICA : OmniSeq and LabCorp Extend Exclusive Distribution Pact and Complete Follow-On Investment Agreement | AQ |
| 04/24 | PROMIS NEUROSCIENCES : to Participate in the Think Equity Investor Conference | AQ |
| 04/24 | AZURRX BIOPHARMA : Exceeds 50% Enrollment Target for Phase II OPTION Clinical Trial | AQ |
| 04/24 | OPTIMIZERX : to Present at Investor Conferences in May | AQ |
| 04/24 | YIELD GROWTH : Application for new INCI name granted for Yield Growths Cannabis Sativa Hemp Root Oil made with Patent Pending Technology | AQ |
| 04/24 | AMERICAN RENAL ASSOCIATES : FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of ARA, NTNX, BA and APYX | AQ |
| 04/24 | BIOCARTIS GROUP NV : Biocartis Announces Global Collaboration with Covance | AQ |
United Kingdom
France
Deutschland
Schweiz (DE)
Prev.
